Previous Article | Next Article 
Journal of Clinical Microbiology, September 2008, p. 3181-3182, Vol. 46, No. 9
0095-1137/08/$08.00+0 doi:10.1128/JCM.01201-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Novel Rapid Culture-Based Detection Method for Methicillin-Resistant Streptococcus aureus

LETTER
In the May 2008 issue of
Journal of Clinical Microbiology, Malhotra-Kumar
et al. (
2) provided an excellent minireview of current trends
in rapid diagnostics for methicillin-resistant
Staphylococcus aureus (MRSA) and glycopeptide-resistant enterococci. In this
article, the authors describe a novel rapid culture-based assay,
the 3M BacLite rapid MRSA test, which detects MRSA without the
need for macroscopic growth of bacterial colonies, allowing
the presence or absence of MRSA to be determined within 5 h.
The article states the assay detects ciprofloxacin-resistant
MRSA and comments that this may lead to the possibility of the
assay not detecting community-acquired MRSA strains, as well
as some hospital-acquired MRSA strains, that are sensitive to
ciprofloxacin. The authors are correct in their statements but
refer to an assay formulation that has not been available since
February 2007, when ciprofloxacin was replaced by cefoxitin
as a selective agent.
The ability of the 3M BacLite rapid MRSA test to detect MRSA strains from a diverse genetic background has been evaluated by von Eiff et al. (4). In an extensive study, more than 700 methicillin-susceptible and methicillin-resistant strains, covering >90% of all registered European MRSA spa types within the SeqNet network, were tested using the 3M BacLite rapid MRSA test. The study reported that all 513 MRSA strains tested were correctly recognized as methicillin resistant while none of the 211 methicillin-susceptible strains were detected as positive. In an additional study (5), 27 MRSA strains recovered from pigs, which have been reported to cause detection problems in some molecular assays, were correctly detected as positive by the 3M BacLite rapid MRSA test. In addition to these analytical studies, there are an increasing number of studies assessing the performance of this assay with clinical specimens. Our group (3) reported a diagnostic sensitivity of 94.6% and a diagnostic specificity of 96.9% for nasal screening swabs and 95.9% sensitivity and 88.8% specificity for groin screening swabs when the assay was referenced to standard operating procedures at three hospital sites in the United Kingdom. More recently Cohen et al. (1) assessed the performance characteristics of the 3M BacLite rapid MRSA assay for a range of body sites compared to chromagar and a commercial molecular assay and concluded that the BacLite assay's performance, ease of use, and capacity best met the needs of the authors' hospital for rapid MRSA screening.
The limitations of traditional diagnostic methods coupled with the increase in antimicrobial resistance means that there is a growing demand among health care providers for rapid microbiological tests to assist patient care and disease control. Malhotra-Kumar et al.'s excellent minireview demonstrates the range of options available to clinical microbiologists today and the fast-moving nature of this field.

REFERENCES
1 - Cohen, D., S. OHara, B. Bagoole, and M. Almeida. 2008. Evaluation of the 3M BacLite rapid MRSA test for the direct detection of MRSA from nasal, groin, and combined nasal/axilla/groin surveillance specimens, abstr. P2132. Abstr. 18th Eur. Congr. Clin. Microbiol. Infect. Dis. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
2 - Malhotra-Kumar, C., K. Haccuria, M. Michiels, M. Ieven, C. Poyart, W. Hryniewicz, and H. Goossens. 2008. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant Enterococcus species. J. Clin. Microbiol. 46:1577-1587.[Free Full Text]
3 - OHara S., S. Gregory, D. Taylor, A. Gough, and N. Foote. 2007. Evaluation of the 3M BacLite rapid MRSA test for the direct detection of MRSA from nasal and groin surveillance specimens, abstr. 540, p. 162-163. Abstr. Annu. Meet. Infect. Dis. Soc. Am. Infectious Diseases Society of America, Arlington, VA.
4 - von Eiff, C., D. Maas, G. Sander, A. W. Friedrich, G. Peters, and K. Becker. 2008. Microbiological evaluation of a new growth-based approach for rapid detection of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 61:1277-1280.[Abstract/Free Full Text]
5 - von Eiff, C., D. Maas, G. Sander, A. Eggemann, A. W. Friedrich, G. Peters, and K. Becker. 2008. Microbiological evaluation of a new growth-based approach designated for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens, abstr. P1760. Abstr. 18th Eur. Congr. Clin. Microbiol. Infect. Dis. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
| | | | | |
Stephen OHara
3M Medical Diagnostics 1 Morley Street Loughborough, Leicestershire LE11 1EP United Kingdom
|
| | | | | |
Phone: 0044(0)7887874392, E-mail: sohara{at}mmm.com |
Authors' Reply

LETTER
We thank Dr. OHara for bringing to attention this important
information not available at the time of our initial publication
(
3). While the previous version of the 3M BacLite rapid MRSA
test would fail to detect community-acquired methicillin-resistant
Staphylococcus aureus (MRSA) and ciprofloxacin-sensitive hospital-acquired
MRSA (
3), the new 3M BacLite assay correctly differentiates
MRSA and methicillin-sensitive
S. aureus (MSSA) strains and
detects MRSA from screening samples, as reported recently (
1,
4). We also validated the new 3M BacLite assay with a limited
number of well-characterized strains (
n = 52) comprising 24
hospital- or community-acquired or animal MRSA strains carrying
SCCmec types I to V or nontypeable
SCCmec cassettes; 5 MSSA
strains; 5 methicillin-resistant, coagulase-negative staphylococci
(MRCoNS); 3 methicillin-sensitive, coagulase-negative staphylococci
(MSCoNS); and 15 strains of other commonly encountered bacteria
(
Escherichia coli,
Enterococcus spp.,
Citrobacter freundii,
Pseudomonas aeruginosa,
Enterobacter cloacae, and
Klebsiella spp.). The BacLite assay correctly identified all 24 MRSA strains
from highly diverse molecular backgrounds, and none of the MSSA
or MSCoNS strains were reported positive by the test. However,
of the five MRCoNS strains, four were identified as MRSA. Also,
among the 15 strains of other bacteria that we tested,
C. freundii and
Enterococcus faecalis (1 strain each) gave false-positive
results. Thus, the diagnostic sensitivity and specificity of
the new 3M BacLite assay were 100% and 79%, respectively, in
our hands with this limited number of samples. Cross-reactivity
with MRCoNS has also been noted by the manufacturers, possibly
because of nonspecific binding of CoNS during the immunomagnetic
separation step. Nonetheless, the BacLite assay cleanly sidesteps
the problems faced by DNA sequence-based detection methods due
to the tremendous sequence variations observed in the
SCCmec cassette (
2), resulting in an impressive sensitivity that should
withstand the constant emergence of novel
SCCmec variants. In
conclusion, the new 3M BacLite assay is a promising assay that
combines the advantages of culture with the rapidity of molecular
method-based detection.

FOOTNOTES

All authors are writing on behalf of the MOSAR WP2 Study Team.


REFERENCES
1 - Cohen, D., S. OHara, B. Bagoole, and M. Almeida. 2008. Evaluation of the 3M BacLite rapid MRSA test for the direct detection of MRSA from nasal, groin, and combined nasal/axilla/groin surveillance specimens, abstr. P2132. 18th Eur. Congr. Clin. Microbiol. Infect. Dis. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
2 - Francois, P., M. Bento, G. Renzi, S. Harbarth, D. Pittet, and J. Schrenzel. 2007. Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 45:2011-2013.[Abstract/Free Full Text]
3 - Malhotra-Kumar, S., K. Haccuria, M. Michiels, M. Ieven, C. Poyart, W. Hryniewicz, and H. Goossens. 2008. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant Enterococcus species. J. Clin. Microbiol. 46:1577-1587.[Free Full Text]
4 - von Eiff, C., D. Maas, G. Sander, A. W. Friedrich, G. Peters, and K. Becker. 2008. Microbiological evaluation of a new growth-based approach for rapid detection of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 61:1277-1280.[Abstract/Free Full Text]
| | | | | |
Surbhi Malhotra-Kumar *
Kelly Haccuria
Liesbet Van Heirstraeten
Margareta Ieven
Herman Goossens
Department of Medical Microbiology Vaccine and Infectious Disease Institute Universiteit Antwerpen Antwerp, Belgium
|
| | | | | |
* Phone: 32-3-820-25-51 Fax: 32-3-820-26-63 E-mail: surbhi.malhotra{at}ua.ac.be |
Journal of Clinical Microbiology, September 2008, p. 3181-3182, Vol. 46, No. 9
0095-1137/08/$08.00+0 doi:10.1128/JCM.01201-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.